Fonte: The Hematology Journal. Nome do evento: Meeting of the European Hematology Association. Unidade: FMRP
Assunto: ANEMIA (GENÉTICA)
ABNT
CALADO, T. et al. The methylenetetrahydrofolate reductase gene polymorphysms and the risk of acquired aplastic anemia. The Hematology Journal. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 16 out. 2024. , 2002APA
Calado, T., Falcão, R. P., Gabellini, S. M., Zago, M. A., & Franco, R. F. (2002). The methylenetetrahydrofolate reductase gene polymorphysms and the risk of acquired aplastic anemia. The Hematology Journal. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Calado T, Falcão RP, Gabellini SM, Zago MA, Franco RF. The methylenetetrahydrofolate reductase gene polymorphysms and the risk of acquired aplastic anemia. The Hematology Journal. 2002 ; 3( supl. 1): 61.[citado 2024 out. 16 ]Vancouver
Calado T, Falcão RP, Gabellini SM, Zago MA, Franco RF. The methylenetetrahydrofolate reductase gene polymorphysms and the risk of acquired aplastic anemia. The Hematology Journal. 2002 ; 3( supl. 1): 61.[citado 2024 out. 16 ]